This prospective, randomized, single-blinded, clinical study aimed at evaluating 3 different synthetic
wound dressings for treating split-thickness skin graft donor sites. Seventy-seven patients were randomly assigned to 3 study groups:
Suprathel, Biatain-Ibu,
Mepitel.
Wounds were inspected daily until complete reepithelization. Ease of care, treatment costs, and
scar development after a 6 months follow-up were evaluated.
Suprathel showed significant (P ≤ 0.001)
pain reduction after 24 hours but increasing
pain scores on the 5th day of treatment. Biatain-Ibu showed significant
pain relief immediately after application and during the entire treatment period (P < 0.05).
Mepitel did not show any significant
pain reduction. No differences were seen with regard to healing time, quality of reepithelization, and
scar development. Biatain-Ibu had the lowest overall treatment costs (P ≤ 0.001). The investigated materials did not differ with regard to quality and acceleration of the healing process, but Biatain-Ibu seems to be the most appropriate dressing material in terms of cost-effectiveness.